Showing results (171-180 of 242) with videos related to
Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Bevacizumab plus irinotecan in recurrent glioblastoma multiformeJames J Vredenburgh, Annick Desjardins, James E Herndon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targetingJohn C Sok, Francesca M Coppelli, Sufi M Thomas, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastomaDavid A Reardon, Scott Turner, Katherine B Peters, et al.Plos One|April 12, 2014
EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastomaHongsheng Miao, Bryan D Choi, Carter M Suryadevara, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathwaysChangcun Guo, Chun-Chi Chang, Matthew Wortham, et al.Neuro-Oncology|March 18, 2009
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Lymphotropic Virotherapy Engages DC and High Endothelial Venule Inflammation to Mediate Cancer <i>In Situ</i> VaccinationAndrea L Ludwig, Zachary P McKay, Griffin P Carter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiformeJennifer A Quinn, Sara Xiaoyin Jiang, James Carter, et al.Cancer Research|September 24, 2017
<i>Cic</i> Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and DifferentiationRui Yang, Lee H Chen, Landon J Hansen, et al.Pageof 25